Álvaro Soto

Another EHA congress in Madrid! A great opportunity for the Physicians to share practices and Pharma industry to present best approaches against hematologic challenges for the optimal disease management and best patient outcome! Bringing hope through science! In a Challenging Landscape find power! #Oncopeptides #Ariti New insights in Multiple Myeloma treatment

131

What about if an single event, we would be able to organize the launch of our next three molecules in our oncology portfolio?. It was the question that Ingrid Oliver our oncology and H&E BUD asked to Synthon México leadership Team. This is how Best Oncologists Symposium (#BOS) by Synthon México. Was thought and created. This event not only represented a milestone in the history of our company, but also reaffirmed our commitment to our patients and the advancement in access to the treatment of different types of cancer. During the symposium, we had the honor of having the participation as speakers of Drs. Dra. Elena Élez, Medical Oncologist/researcher at the Vall d'Ebron Institut d'Oncologia de Barcelona Spain, Dr. German Calderillo, Medical Oncologist/researcher at the INCAN CDMX, Mexico, Dr. Ernesto Maturana, Medical Oncologist at the Red Salud Cancer Institute and Sotero del Rio Hospital, Santiago de Chile. And as coordinator, Dr. María del Consuelo Diaz, Medical Oncologist/researcher at INCAN. Their lectures not only highlighted the efficacy, safety and benefits of Biocomparable and bioequivalent products, but also fostered an enriching dialogue about the future of oncology. In addition to scientific presentations, these meetings are essential to continue advancing our mission of improving the quality of life of patients through effective, safe and cost-saving oncological treatments. At #BOS we announced our new launches intended to treat specific types of cancer such as prostate, colon and kidney cancer. These three types of cancer represent a significant economic burden globally as well as in Mexico: Avitosyn (Abiraterone), Simbiva (Bevacizumab), and (Axitinib), not only represent our commitment to developing products of the highest European quality for safety and efficacy, but also offer important cost-effectiveness benefits. Being generic and biocomparable treatments, our products allow the health budgets of both government and private institutions. By adding this new products to our high specliazed growing portfolio, we can provide greater choice to physicians and patients whilst offering the potential for significant cost-saving across healthcare System in Mexico. At Synthon México 🇲🇽, are proud to see how our R&D pourpuse has translated into real benefits for patients. This event not only validated our dedication and commiment, also reinforced the importance of collaboration and working together to address one of the most significant challenges in modern medicine. The launch of our new oncology products at #BOS not only met our expectations, but by far exceeded them. We are convinced that our treatments presented will make a significant difference in access to and treatment of cancer, and will benefit a greater number of patients. On behalf of Synthon México , I thank all participants for their invaluable contribution and commitment to the health and well-being of Mexican patients.

127

12 comentarios

X-ray of the Colombian pharmaceutical market. Total sales: The pharmaceutical industry generated revenues of 1.25 trillion dollars worldwide in 2020. The main producers of medicines in the world include the United States, China, Japan and Brazil. Among the total global sales, only 3.5% are directed to Latin America4. Within the region, Colombia is the fifth market, with sales of 19.7 billion pesos in 2021 and a growth projection of up to $25 billion pesos in 20255. In Colombia, sales of patented medicines represent 41% of total sales, generic medicines 42% and over-the-counter (OTC) medicines 17%6. Channels: 66% of pharmaceutical market sales were distributed in the institutional channel and 34% in the commercial channel (2021). The marketing of several molecules is expected to migrate from the commercial channel to the institutional channel as a result of the recent comprehensive technology update: 600 drugs and 668 procedures, which represent 93.5% of coverage in the Health Benefits Plan under the UPC7. I. Trade balance: Colombia has a trade balance deficit, with a 92% share of imports versus 8% of exports in total foreign trade of pharmaceutical products. This shows a strong dependence on imports not only in Colombia, but in other countries in the region, where exports have only just begun to strengthen in recent years. In the last year, a 7% growth rate in exports was recorded. Among the exported products, 93% are medicines, 5% biological products and the remaining 2% is equivalent to organic chemicals, vitamins and antibiotics. The destination of medicine exports is distributed as follows: 88% Latin America, 3% Europe and 6% North America (in FOB 2021 values). Imports grew 54% in 2021, reaching 4.144 billion CIF dollars. Colombia's main suppliers are located in the following regions: 42% Europe, 29% North America and 23% Asia (in CIF 2021 values).

1

💪🏼27,000 Young Lives Impacted: Adolescent Pregnancy Prevention Success in Xochimilco We are proud to share the remarkable progress in preventing adolescent pregnancy in Xochimilco, Mexico. This initiative, born from a powerful coalition of organizations and authorities, showcases the transformative impact of strategic partnerships. Key partners include: * Organon México * UNFPA Latin America and the Caribbean México * National Population Council (CONAPO) * Xochimilco local authorities (Mayor's office, Youth Research Center A.C.) * Mexico City authorities (Health Secretary - Public Health Services, Human Rights Commission) * Civil society organizations (Petit Fils) In just two years, our comprehensive strategy has positively influenced over 27,000 young lives through: 1. Comprehensive sexuality education and sexual/reproductive rights awareness 2. Access to youth-friendly health services 3. Professional family planning counseling 4. Support for personal growth and life planning We extend our heartfelt gratitude to all partners for their unwavering dedication. This achievement marks only the beginning of what we can accomplish by uniting for a healthier, more promising future for our youth. At Organon, empowering young people with knowledge and choices for a brighter future is central to our mission. We are #HereForHerHealth because #HerPromiseOurPurpose. Our purpose is to help women and girls achieve their promise through better health and is inextricably linked to our company vision: to create a better and healthier every day for every woman around the world. This project represents a significant milestone in our commitment to Mexico's youth. Every young person deserves the opportunity to make informed decisions about their health and future. We're honored to play a role in making this possible. #ReproductiveHealth #AdolescentWellbeing #StrategicPartnerships #SocialImpact #OrganonLAMEX #HereForHerHealth https://lnkd.in/dWpnUTWU #ReproductiveHealth #ZeroAdolescentPregnancies #StrategicAlliances #SocialImpact #OrganonLAMEX #HereForHerHealth #PorLaSaluddeEllas

69

1 comentario

Partnerships are critical in improving access to healthcare. Aliados por la Salud is a collaboration between Roche, Salud Digna and BBVA working to improve early HPV diagnosis and prevent cervical cancer. This multi-sectoral partnership is paving the way to better health. Nearly 600,000 molecular HPV tests have already been used to fight cancer, and more to come. #TogetherForChange #Partnerships #XProject

16

This is a good reflection if we want to drive change in healthcare. We’ve seen how diabetes treatment has evolved in recent years, but we also know there are still unmet needs and much more to be done. Currently in Latin America, more than 33 million adults live with diabetes and about half of them are undiagnosed. In Novo Nordisk LATAM we are committed to improving the quality of life for patients. We never stop thinking about this, and we continue to seek ways to innovate even further, so people with diabetes can live well today, tomorrow, and in the future. #DrivingChangeinDiabetes #WorldDiabetesDay

70

🌟 Navigating Regulatory Changes in Mexico: What’s Next for Pharma? 💊 Mexico’s regulatory landscape for pharmaceuticals is evolving rapidly, with COFEPRIS introducing reforms to enhance compliance and align with global standards. While these updates aim to foster innovation and increase patient safety, they also present unique challenges for local businesses. 🚨 Key Risks: Stricter requirements for GMP compliance and pharmacovigilance systems. Enhanced scrutiny on biosimilars and bioequivalence studies, adding complexity to approval processes. Increased costs for regulatory alignment, which may strain smaller manufacturers. 🎯 Opportunities to Adapt: Build internal expertise to manage shifting regulatory demands. Partner with third-party evaluators and consultants to streamline compliance. Leverage COFEPRIS’s drive for international alignment to access global markets. Mexico is on its way to becoming a leader in pharmaceutical innovation, but businesses must proactively prepare to navigate the transition. Staying informed and agile will be critical for success in this competitive and evolving market. What’s your take on these regulatory changes? Let’s discuss! 👇 #Pharmaceuticals #RegulatoryAffairs #Mexico #HealthcareInnovation #Compliance

6

Good news! Teva has launced a new program that donates vital medicines to underserved communities in El Salvador. Working in collaboration with Americares and FUSAL, this effort ensures that everyone, regardless of their circumstances, has access to a #HealthyFuture. In El Salvador, many patients face significant barriers that prevent them from getting the treatments they need. Through this program, we are addressing critical health needs related to cardiovascular diseases, diabetes, respiratory illnesses and pain and palliative care. Our goal is to bring hope and healing to those who need it most. This program joins seven others providing treatments to underserved populations worldwide, and we are proud to have reached our goal of launching eight access to medicines programs by 2025 ahead of schedule. Programs like this are a testament to our commitment to #HealthEquity. By working closely with our partners, we deliver customized, localized solutions that truly make a difference. We invite you to read more about how we are bringing essential treatments to patients who otherwise wouldn’t have them: https://lnkd.in/eWN-8sZd #HealthyPeople #Tevapharm #CommunityCare #PatientCentricity

4

Today, we reflect on the importance of communication as a preventive measure against this disease, which has increased and affects more than 500 million people worldwide. Mexico has become one of the countries with the highest prevalence of this disease. According to the National Health and Nutrition Survey (Ensanut) 2022, it is estimated that nearly 12.6% of the Mexican population, that is, more than 14 million people in our country, have been diagnosed with Diabetes. Additionally, as indicated in this survey, overweight and obesity have shown sustained growth in all population groups, being among the main identified risk factors for type 2 diabetes mellitus, with around 70% of the Mexican population reported as overweight and obese. In Avant Santé, we promote clinical research, which creates opportunities for our community, considering the heavy burden of Diabetes in our population. #Diabetes #Prevention #Awarenes #ClinicalResearch #PatientCentric

17

From Transformational Leadership to "Mano tengo fe (Bro, I Have Faith)" Considering the current football championships in Europe and America, I felt compelled to draw a parallel between what happens in a sports team and within organizations, particularly focusing on the role of leaders in driving their team members to excel and achieve organizational goals. To illustrate how a leader can influence team performance, let's consider the Venezuelan soccer team. Historically, Venezuela has not been a standout in the soccer world, but in the recent Copa América, they emerged as one of the tournament's revelations. What sparked this significant change? It boils down to a shift in the vision of their leaders, who have instilled a belief not only in the team members but also in the entire nation, epitomized by their popular slogan: "Bro, I have faith." But what does faith mean in organizational contexts, and what is the leader's role in this equation? This is where transformational leadership comes into play. Transformational leaders seek to inspire and motivate employees to achieve significant and positive changes within the organization. They do this by: ·      Communicating an Inspiring Vision: Offering a clear and compelling picture of the future that excites and motivates employees. ·      Acting with Integrity and Ethics: Building trust and earning the unwavering support of their team. ·      Effective Communication: Engaging employees with clear and persuasive communication. ·      Fostering Creativity and Innovation: Encouraging new ideas and approaches by challenging existing assumptions. ·      Providing Individualized Attention: Acting as mentors and coaches, recognizing, and developing each employee's unique strengths and talents. ·      Being Agents of Change: Leading initiatives that drive transformation within the organization. Just like in soccer, leaders must understand their role in developing their team's competencies without compromising their autonomy, enabling them to seize various market opportunities. Therefore, transformational leadership is essential in dynamic and ever-changing environments, where the ability to adapt and lead significant changes is crucial for long-term organizational success and to be able to say “Bro, I have faith.” #leadership #transformationalleadership #innovation #people #organizations

58

13 comentarios

Good news! Teva has launced a new program that donates vital medicines to underserved communities in El Salvador. Working in collaboration with Americares and FUSAL, this effort aims to expand patients' access to a #HealthyFuture. In El Salvador, many patients face significant barriers that prevent them from getting the treatments they need. Through this program, we are addressing critical health needs related to cardiovascular diseases, diabetes, respiratory illnesses and pain and palliative care. Our goal is to bring hope and healing to those who need it most. This program joins seven others providing treatments to underserved populations worldwide, and we are proud to have reached our goal of launching eight access to medicines programs by 2025 ahead of schedule. Programs like this are a testament to our commitment to #HealthEquity. By working closely with our partners, we deliver customized, localized solutions that truly make a difference. We invite you to read more about how we are bringing essential treatments to patients who otherwise wouldn’t have them: https://lnkd.in/dGwwNads #HealthyPeople #Tevapharm #CommunityCare #PatientCentricity

14

🎞 #ChatsWithChaudhrey S05E36 with SciY’s President Santi Dominguez Sept 24 2024 I had the pleasure of sitting down with Santi, SciY's President and co- founder and CEO of Mestrelab Research S.L. and had a wide ranging conversation covering everything from how do you create a culture for a new business made up of six companies who have their own culture, to how you get customer buy in that you are vendor agnostic when your parent company is seen as competitor in the sector, to what are the pain points for labs to become digital, to what the future trends will be. I hope you enjoy listening to conversation as much as I had having it. I asked Santi.... ▣ First can you give viewers an overview of SciY The company’s background and the technologies you offer? 01:06 ▣ What is SciY mission and vision, and what are the company’s core values? 03:36 ▣ What are the core values now, and how do you incorporate the values from the original companies? 05:46 ▣ How easy is it to convince customers that #SciY are truly vendor agnostic given its part of Bruker? 09:19 ▣ Did the pandemic change companies mind sets with regards working with competitors? 14:19 ▣ Why SciY? What does the name signify, and why was the letter 'Y' chosen as a part of the company's name at the end? 16:27 ▣ What are the pinpoints do you see for labs in terms of #digitisation? 18:58 ▣ Do you think that the momentum for digitisation with Pharma has continued since the pandemic or do you think it has slowed down? 27:39 ▣ Looking ahead what future trends do you see , and how is SciY preparing for them? 30:32 ▣ What makes SciY and your solutions different to other companies in the market? Why should companies work with you? 37:22 If you have any questions or comments about anything we discussed, or want to learn more about SciY, feel free to leave a comment below, or get in touch with Santi via LinkedIn, or meet the team at numerous events. You can also learn more using the links below 💻 SciY website https://lnkd.in/e_95WT8r 💻 SciY Solutions https://lnkd.in/eJcgRfxE 💻 SciY Platforms https://lnkd.in/e5tCWNtW 💻 SciY blog https://lnkd.in/eNctFyYq #RSKSciY #LabIntegration #AI #MachineLearning #DataIntegartion Guliafshan Tariq Marco S. Guy Desmarquets Monika Bredschneider - Partner Management Farrel Borden Adham Chebbani Stéphane Pitout Amanda Lashua, PhD Gianna Zischka Adrienne Lemieux Sina Kazemi Carolin Frohnapfel https://lnkd.in/e8Ejs-eq

9

As we commemorate Takeda's 60th anniversary in Mexico, I am deeply thankful to Executive Forecast for the opportunity to participate in this interview. Takeda's evolution in Mexico over these 6 decades has been truly remarkable and has brought us to where we are today: an established biopharmaceutical leader specializing in innovative therapies for our patients. It was truly an honor to share Takeda Mexico's rich legacy and a part of our history: -60 Years in Mexico: In 2024, we will be celebrating a legacy of 6 decades in Mexico, enhancing the well-being of our patients and their families. -Mexico's Strategic Importance: Mexico is the first country with fully integrated operations for Takeda, including Commercial Operations, a Manufacturing Site, and an Innovation Capability Center. -Commitment to Integrity and Trust: We maintain a legacy of integrity, prioritize patient needs, foster a diverse and inclusive workforce, and focus on environmental sustainability. -Comprehensive Transformation: Over the last 5 years, we have transitioned into a biopharma and specialty care leader, driven by sustainable growth through innovation, ensuring access through collaboration, and building on internal talent and values. -Digitalization and AI: We use digital data and technology to enhance R&D and manufacturing, improve the patient experience, and support HCPs. #Takeda #Innovation #243Years

47

1 comentario

Artificial Intelligence (AI) has evolved from a futuristic concept into a transformative force in healthcare. In my latest article for Mexico Business News, I provide my perspective on how AI is revolutionizing #healthcare, from more accurate diagnoses to the accelerated development of innovative drugs. Read the full article to see how AI is reshaping healthcare! https://bit.ly/3zHg8RG #BMS_Employee #HealthcareTech #AI

68

2 comentarios

I am pleased to share that we have launched a new program to donate medicines to under-served communities in El Salvador. Working in collaboration with Americares and FUSAL, this initiative upholds our belief that everyone, regardless of their circumstances, deserves access to a #HealthyFuture.   Latin America is a key region for Teva International Markets, and I am proud that we can help address the significant health challenges in El Salvador. The country's healthcare system is under immense strain, with limited access to services and insufficient medical infrastructure.   Our program will focus on reaching patients living in poverty in two central cities, San Salvador and Santa Tecla. We will donate medicines to treat critical health needs related to cardiovascular diseases, diabetes, respiratory illnesses, pain and palliative care. Our goal is to bring hope and healing to those who need it most. We are deeply committed to supporting our communities, sustainability and #HealthEquity. By working closely with our partners, we deliver customized, localized solutions that truly make a difference. Read more about how Teva is bringing essential treatments to patients who otherwise wouldn’t have them: https://lnkd.in/dGu8sEDe   We are all in for better health. #HealthyPeople #TevaPharm #CommunityCare #PatientCentricity #ElSalvadorHealth #AccessToCare #CommunitySupport Amalia Adler-Waxman Sheana Shechterman Orit Braverman Teva Pharmaceuticals Teva México Teva en Argentina Laboratorio Chile | Teva Rodrigo Fernandez Vanina Faillace Juan Martin Meli Roberto Rego Vieira da Rocha José Luis Cárdenas Tomazic Bárbara Díaz Ostheimer Marcella Barbosa Paula Bravo Ithurbisquy Mónica Castelazo

180

8 comentarios

Join Our Mission at Rarus Health SPA! During the last few months, our database of patients with #rarediseases has grown significantly. Our users are now spread across #Chile, #Argentina, #Mexico, #Colombia, and #Bolivia. The majority of them are caregivers (let's be plain – moms) of kids with rare genetic diseases, mainly neurological ones. Having experience working with patients from other parts of the world (mainly EU, Russia, CIS, and US), I see clear differences between them: 💡 Average Age: In Latin America, both patients and caregivers tend to be older. This is likely due to a longer diagnostic journey and limited availability of geneticists. 💡Digital Literacy: There is a significant gap here! Our app has a lengthy onboarding process (similar to digital banking) for safety reasons. We’ve noticed how challenging this is for our users in Latin America! People often get lost if they need to take more than two steps. I talked to a number of UX designers that work in LatAm and they confirmed these observations. 💡Asking Questions: Frankly, not asking questions 🙄 . Based on my previous experience, every patient with a rare disease seeks a second opinion, challenges the doctor, and asks complicated questions whenever they can get additional information. I’ve even had scientific discussions with some moms at rare diseases conferences, and it was not nonsense 😄 ! However, patients here definitely need more support to express their opinions, especially to doctors. At Rarus Health SPA , we focus on patients' needs, and this is our core value. That’s why it's time to find a #Productmanager with focus on #userresearch, who will help us understand our customers better, follow up with our wonderful users, and ensure our product delivers its full value. Are you passionate about making a difference in the lives of patients with rare diseases? Do you have experience in user research and a knack for connecting with people? Native Spanish and understanding of LatAm cultural sets is a must. If so, we’d love to hear from you!   📢 Apply now or share this post with someone who might be the perfect fit. 🔔 Do you know someone like that? Tag them in the comments! ## Job description in the first comment 👇

18

1 comentario